Latest Announcements

Lodha Developers Ltd's Q1FY27 earnings conference call transcript was released, with management highlighting 20% PAT growth guidance, strong residential engine, and land monetization plans. Revenue was INR 50 billion, up 43% YoY, with adjusted EBITDA at INR 21.5 billion and PAT at INR 13.7 billion. Net debt was reduced by INR 4.5 billion to under INR 50 billion.

Jasch Gauging Technologies Ltd has announced unaudited standalone financial results for the quarter ended 30.06.2026, with revenue from operations at Rs. 1,468.24 lakh and profit from continuing operations at Rs. 368.51 lakh. The company has also declared an interim dividend of Rs. 10 per equity share.

Fairchem Organics Ltd. has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 176 crores, a 34.4% year-on-year increase. EBITDA for the quarter was Rs. 18 crores with an EBITDA margin of 10.14%. The net profit for the quarter was Rs. 10 crores.

Paushak Ltd announced its unaudited financial results for the quarter ended 30th June, 2026, with a profit before tax of Rs 1,902 lakhs, a tax expense of Rs 391 lakhs, and a profit after tax of Rs 1,510 lakhs. The company's earnings per share (EPS) for the quarter was Rs 6.13.

Niva Bupa Health Insurance Company Ltd has announced its Q1FY2027 results, with a 31.7% y-o-y growth in Gross Written Premium (GWP) to ₹ 2,150 crore and a near doubling of Profit After Tax (PAT) to ₹ 137.8 crore. The company has also transitioned to Indian Accounting Standards (Ind AS) from Q1FY2027, which is expected to enhance financial transparency and align reporting practices with global benchmarks.

Jasch Gauging Technologies Ltd has announced unaudited standalone financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 1,468.24 lakhs and profit from continuing operations at Rs. 368.51 lakhs. The company has also declared an interim dividend of Rs. 10 per equity share.

Ramkrishna Forgings Ltd has released the transcript of its Q1 FY27 earnings conference call, highlighting strong operational and financial performance driven by robust domestic demand, improving export volumes, and disciplined execution.

Swiggy Ltd reported unaudited financial results for Q1FY27, with overall revenue growing 34.0% YoY to INR 7,112 Cr, and Food Delivery business Gross Order Value (GOV) growing 17.4% YoY to INR 9,490 Cr. Adjusted EBITDA improved by INR 100 Cr YoY to INR 292 Cr, and Quick Commerce hit Contribution break-even in May'26.

Mankind Pharma Ltd reported Q1FY27 financial results with revenue growth of 12.9% YoY, EBITDA growth of 24.7% YoY, and PAT growth of 29.1% YoY. The company's domestic business (ex-CH) grew by 11.0% led by double-digit growth in Mankind domestic business, while OTC segment grew by ~4% and International business grew 29% YoY.

Swiggy Ltd has announced its Q1 FY 2026-27 Shareholders' Letter, highlighting the company's achievement of contribution margin break-even in quick commerce. The letter also discusses the company's growth, user base, economics, and experience, as well as its plans to expand its network and launch new initiatives.

Mankind Pharma Ltd has announced its Q1FY27 investor presentation, showcasing a 12.9% YoY growth in revenue from operations, with domestic business (ex-CH) growing 10.5% YoY and exports business growing 29% YoY. The company has also reported a 16.5% YoY growth in gross profit and a 24.7% YoY growth in EBITDA. The presentation highlights the company's steady growth trajectory, expansion in specialty and super specialty segments, and strong performance in key focused brands.

Bajaj Finance Ltd has announced its Q1 FY27 investor presentation, highlighting excellent quarter performance across key metrics. AUM grew by 24% to ₹ 546,944 crore, with new customer additions and credit costs improving. The company expects to disburse 60-62 MM new loans in FY27 and add 18-20 MM new customers to its franchise.

Colgate Palmolive (India) Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a 12% net sales growth and an 11% net profit growth, excluding one-offs and exceptional items. The company has also highlighted its achievements and financial performance during the FY 2025-26, including winning several awards and honors for its innovative products and sustainability initiatives.

Tamilnad Mercantile Bank Ltd has announced the transcript of its Q1 FY27 earnings conference call, where the bank reported a 23% growth in total business, 19.71% growth in deposits, and 27.01% growth in advances. The bank's net interest income and net profit have also seen significant increases, with the latter being an all-time high.

Garden Reach Shipbuilders & Engineers Ltd has received a ₹1032.07 Crore contract from ONGC for the construction of four platform supply vessels.

Mahindra & Mahindra Ltd's Chairman delivered a speech at the 80th Annual General Meeting, highlighting the company's resilience and growth in an uncertain global environment. The company has achieved historical highs, invested in R&D, and made a significant investment in Nagpur. The Chairman emphasized the need for the company to accelerate and move from navigation to acceleration, adopting an 'Attack Mode' approach.

Infosys Finacle, a subsidiary of Infosys, has announced that Investec, a leading international bank and wealth manager, has selected the Finacle Digital Banking Solution Suite on Microsoft Azure for digital banking transformation across South Africa, the UK, Mauritius, and the Channel Islands.

Oil India Ltd has signed a Memorandum of Understanding (MoU) with the Municipal Corporation of Delhi (MCD) to establish Compressed Bio-Gas (CBG) plants based on segregated organic municipal solid waste in Delhi.

Fischer Medical Ventures Ltd has received CDSCO import approval for Spincare, a portable electrospun wound care system, marking a significant regulatory milestone in India's rapidly growing advanced wound care market.

Mankind Pharma Ltd's board meeting outcome announced financial results for Q1 2026, with corporate guarantee issued in favour of Bharat Serums and Vaccines Ltd, and unaudited standalone financial results reviewed by S.R. Batliboi & Co. LLP and Bhagi Bhardwaj Gaur & Co.